ADIAL PHARMACEUTICALS INC
ADIL · NASDAQ
Updated at 2026-10-14 09:31:18
- Today's High
- $3.87
- Today’s Low
- $3.20
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $4.04
- Previous Close
- $3.50
- Volume
- 167.09K
- Market Cap
- $9.19M
- P/E Ratio
- --
- EPS
- $-16.57
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 4870 SADLER ROAD, GLEN ALLEN, VA, UNITED STATES, 23060
- Country
- US
- Listing Date
- 2018-07-27
- Fiscal Year End
- December
- Shares Outstanding
- 2.58M
- CIK
- 0001513525
- Website
- www.adialpharma.com
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapies for the treatment or prevention of addictions and related disorders. The company is headquartered in Charlottesville, Virginia.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$52.02M
2026-03-31
$2M
2025-12-31
$1.88M
2025-09-30
$1.76M
Net Income
2026-06-30
-$51.98M
2026-03-31
-$2.02M
2025-12-31
-$1.99M
2025-09-30
-$1.79M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-11.25
2026-03-31
$-1.48
2025-12-31
$-11.48
2025-09-30
$-2.00
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$51.98M
2026-03-31
-$2.02M
2025-12-31
-$1.99M
2025-09-30
-$1.79M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $52.02M | $2M | $1.88M | $1.76M |
| Net Income | -$51.98M | -$2.02M | -$1.99M | -$1.79M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-11.25 | $-1.48 | $-11.48 | $-2.00 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$51.98M | -$2.02M | -$1.99M | -$1.79M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.